Case report of Mikulicz`s disease – a modern concept of an old entity

  • Ksenija Svetozar Bozic Clinic of Rheumatology, Military Medical Academy, Belgrade, Serbia;
  • Branislava Glišić Clinic of Rheumatology, Military Medical Academy, Belgrade, Serbia, Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
  • Olga Radić-Tasić Institute of Pathology, Military Medical Academy, Belgrade, Serbia
  • Bojana Knežević Clinic of Rheumatology, Military Medical Academy, Belgrade, Serbia
Keywords: mikulicz' disease, diagnosis, differential, lacrimal apparatus, salivary glands, immunoglobulin G, histological techniques, glucocorticoids, treatment outcome,

Abstract


Introduction. Modern knowlegde defines Mikulicz´s disease as a part of immunoglobulin G4-related disease. The main feature is the presence of lymphoplasmacytic infiltrates, immunoglobulin G4 plasma cells positivity, distinctive storiform fibrosis and moderate eosinophilia. Case report. A 59-years old male presented with a mild keratoconjuctivitis sicca and enlarged lacrimal and salivary glands during the last two years. Althought clinical presentation of the patient was typical, earlier testing did not pinpoint Mikulicz´s disease. By typical clinical presentation, elevated serum immunoglobulin G4 level and histopathological finding of lacrimal glands tissue we diagnosed Mikulicz´s disease successfully treated with corticosteroid therapy. Conclusion. We reported the first case of IgG4-related Mikulicz´s disease in Serbia. Our report highlights IgG4-related Mikulicz`s disease as an important differential diagnosis with Sjögren`s syndrome and lymphoproliferative disease in rheumatological practice.


Author Biography

Ksenija Svetozar Bozic, Clinic of Rheumatology, Military Medical Academy, Belgrade, Serbia;
Clinic of Rheumatology

References

Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23(1): 57−66.

Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with scleros-ing pancreatitis. N Engl J Med 2001; 344(10): 732−8.

Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions compli-cating autoimmune pancreatitis. J Gastroenterol 2006; 41(12): 1197−205.

Yamamoto M, Takahashi H, Sugai S, Imai K. Clinical and patho-logical characteristics of Mikulicz's disease (IgG4-related plas-macytic exocrinopathy). Autoimmun Rev 2005; 4(4): 195−200.

Guma M, Firestein GS. Best Practice. Res Clin Rheumatol 2012; 26(4): 425−38.

Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Ya-mamoto H, et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006; 16(6): 335−40.

Mikulicz JH. Uber eine eigenartige symmetrische Erkrankung der Tranen- und Mundspeicheldrusen. Stuttgart: Beitr Chir Fortschr; 1892.

Napp O. Über die Beziehungen der Mikuliczschen Erkrankung Tuberkulose. Stschr Augenheilk 1907; 17: 513.

Schaffer AJ, Jacobsen AW. Mikulicz's syndrome: a report of ten cases. Am J Dis Child 1927; 34(3): 327−46.

Sjögren HS. Zur kenntnis der keratoconjunctvitis sicca (Keratitis folliformis bei hypofunktion der tranendrusen). Acta Op-thalmol (Copenh) 1933; 2: 1−151.

Morgan WS. The probable systemic nature of Mikulicz's disease and its relation to Sjögren's syndrome. N Engl J Med 1954; 251(1): 5−10.

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012; 22(1): 1−14.

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22(1): 21−30.

Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366(6): 539−51.

Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68(8): 1310−5.

Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23(1): 67−71.

Published
2017/02/01
Section
Case report